Figures are presented in US dollars.
Revenue (in thousands)
Foundations: $161,651
US government: $114,966
Other governments, nongovernmental organizations (NGOs), multilaterals : $52,571
Corporations: $11,006
Investments: $10,090
Individuals/other: $2,429
TOTAL REVENUE: $352,714
Expenses (in thousands)
Program-related:
Programs & Innovation: $95,807
Essential Medicines: $46,392
Africa: $40,385
Asia, Middle East, and Europe (AMEE): $34,824
Other: $4,811
Program development: $3,085
Subawards to program partners: $93,335
Subtotal program-related: $318,639
Administrative: $31,636
Fundraising: $1,521
TOTAL EXPENSES: $351,796
Assets (in thousands)
Invested grant funds: $188,619
Cash and cash equivalents: $85,582
Contributions and awards receivable: $6,286
Right-of-use assets: $29,441
Other: $15,230
TOTAL ASSETS: $355,158
Liabilities and net assets (in thousands)
Total liabilities: $301,561
Net assets:
With donor restrictions: $26,972
Without donor restrictions: $26,625
Total net assets: $53,597
TOTAL LIABILITIES AND NET ASSETS: $355,158
The above financial summary is based on PATH’s audited financial statements, which are audited by the firm Clark Nuber P.S. Full copies are available on our finances page.
PATH is an international, nonprofit, nongovernmental organization. Our mission is to advance health equity through innovation and partnerships. Contributions to PATH are tax-exempt under US IRS code 501(c)(3).